Working... Menu

Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02588677
Recruitment Status : Completed
First Posted : October 28, 2015
Last Update Posted : December 17, 2018
Information provided by (Responsible Party):
AB Science

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 5, 2016
  Actual Study Completion Date : March 2018
  Certification/Extension First Submitted : December 12, 2018